Trupanion (TRUP)
(Delayed Data from NSDQ)
$31.30 USD
+0.93 (3.06%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $31.25 -0.05 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$31.30 USD
+0.93 (3.06%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $31.25 -0.05 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Zacks News
Trupanion (TRUP) Loses -26.63% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Trupanion (TRUP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Hartford Financial (HIG) Q3 Earnings Beat on Commercial Lines Unit
by Zacks Equity Research
Hartford Financial's (HIG) Q3 results reflect growing premiums in the Group Benefits business and improved net investment income, partly offset by higher expenses.
AMERISAFE (AMSF) Q3 Earnings Miss on Lower Premiums Earned
by Zacks Equity Research
AMERISAFE's (AMSF) board declares a special dividend of $3.50 per share to return excess capital to shareholders.
Trupanion (TRUP) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amerisafe (AMSF) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of -4.69% and 0.24%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Central Garden & Pet (CENT) Advances in 3 Months: Here's Why
by Zacks Equity Research
Central Garden & Pet (CENT) is taking proactive approaches to solidify its position in the competitive pet supplies, and lawn and garden products market in the United States.
Here's Why You Should Consider Investing in Trupanion (TRUP)
by Zacks Equity Research
Trupanion's (TRUP) heightened focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position poise it well for growth.
HCI Group's (HCI) TypTap Gets Regulatory Nod to Assume Policies
by Zacks Equity Research
Per the regulatory approval, HCI Group's (HCI) subsidiary TypTap will assume up to 25,000 policies from Florida's Citizens Property Insurance Corporation.
Here's Why Hold Strategy is Apt for eHealth (EHTH) Stock Now
by Zacks Equity Research
eHealth's (EHTH) transformation initiatives are lowering its costs and expanding margins.
Here's Why You Should Retain MarketAxess (MKTX) Stock for Now
by Zacks Equity Research
Higher commissions, new data contract revenue, growing international business and improved liquidity poise MarketAxess (MKTX) well for growth.
Manulife's (MFC) John Hancock Launches New Insurance Product
by Zacks Equity Research
Manulife's (MFC) John Hancock enhances its product portfolio by launching the Premier Benefit Indexed Universal Life product.
Allstate (ALL) Continues Auto Rate Hikes to Boost Profits
by Zacks Equity Research
Allstate (ALL) reports estimated catastrophe losses of $435 million after taxes in August.
Why You Should Add Brown & Brown (BRO) Stock to Your Portfolio
by Zacks Equity Research
Solid new businesses, premium-rate increases across the majority of business lines, expansion initiatives, strategic acquisitions and a strong financial position continue to drive Brown & Brown (BRO).
CME Group (CME) to Introduce Cobalt Hydroxide Futures on Oct 23
by Zacks Equity Research
CME Group (CME) is set to address the need for a hedging instrument in the battery space with the launch of Cobalt Hydroxide futures.
Wall Street Analysts Predict a 25.01% Upside in Trupanion (TRUP): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 25% in Trupanion (TRUP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
CME Group (CME) to Introduce Options on Micro Gold Futures
by Zacks Equity Research
CME Group (CME) introduces options on Micro Gold Futures to cater to the growing demand for gold products.
AON Stock Jumps 14% in a Year: More Growth on the Horizon?
by Zacks Equity Research
AON is poised for long-term growth on the back of Strategy and Technology Group performance, talent investments, and improving operations in multiple regions.
Manulife (MFC) Enhances Product Suite With New Medicine Program
by Zacks Equity Research
Manulife (MFC) launches Personalized Medicine Program for Enhanced Health Care members in Canada.
Here's Why You Should Add Primerica (PRI) to Your Portfolio
by Zacks Equity Research
Higher premiums in term life insurance, increasing sales force and improving senior health business should poise Primerica (PRI) well for growth.
Here's Why You Should Hold MarketAxess' (MKTX) Stock Now
by Zacks Equity Research
MarketAxess' (MKTX) Adaptive Auto-X solution adds further strength to its suite of automated trading solutions.
Here's Why You Should Retain AMERISAFE (AMSF) Stock Now
by Zacks Equity Research
Improving retention, a high-interest rate environment and a robust balance sheet poise AMERISAFE (AMSF) well for growth.
Why Investors Are Snapping Up ProAssurance (PRA) Stock Now
by Zacks Equity Research
ProAssurance's (PRA) higher investment returns, thanks to a high interest rate environment, will keep benefiting the company's results.
MetLife (MET) Stock Rises 19.5% in 3 Months: More Room to Run?
by Zacks Equity Research
MetLife's (MET) cost-curbing initiatives are likely to lower expenses, increase efficiency and boost profit levels.
Aflac (AFL) Collaborates With LTIMindtree for Cloud Migration
by Zacks Equity Research
Aflac (AFL) selects LTIMindtree to aid it in the digital transformation journey and cloud migration.
How Are Rate Hikes Aiding Allstate (ALL) to Combat Inflation?
by Zacks Equity Research
Allstate (ALL) reports estimated catastrophe losses of $247 million after taxes in July.